Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matejka Rebolj

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|December 16, 2021
Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilotMatejka Rebolj, Christopher S Mathews, Francesca Pesola, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.
BMC Infectious Diseases|July 28, 2014
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray systemJesper Bonde, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMJ (Clinical Research Ed.)|May 31, 2022
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot dataMatejka Rebolj, Kate Cuschieri, Christopher S Mathews, et al.
BMC Cancer|July 22, 2016
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySarah Preisler, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMC Health Services Research|November 26, 2022
Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statisticsJames Alexander Doorbar, Christopher S Mathews, Karin Denton, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2013
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assayMatejka Rebolj, Sarah Preisler, Ditte M Ejegod, et al.
Scandinavian Journal of Public Health|March 7, 2015
Mothers' and their daughters' use of preventive measures against cervical cancerBente Braad Sander, Miguel Vázquez-Prada, Matejka Rebolj, et al.
Endoscopy International Open|May 6, 2024
Adherence to follow-up and resource use after abnormal FIT-screening: Evaluation of the Danish colorectal cancer screening programSusanne Fogh Jørgensen, Pernille Thordal Larsen, Rune Erichsen, et al.
International Journal of Cancer|April 22, 2026
Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised TrialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
BJOG : an International Journal of Obstetrics and Gynaecology|December 16, 2021
Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilotMatejka Rebolj, Christopher S Mathews, Francesca Pesola, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.
BMC Infectious Diseases|July 28, 2014
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray systemJesper Bonde, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMJ (Clinical Research Ed.)|May 31, 2022
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot dataMatejka Rebolj, Kate Cuschieri, Christopher S Mathews, et al.
BMC Cancer|July 22, 2016
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySarah Preisler, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMC Health Services Research|November 26, 2022
Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statisticsJames Alexander Doorbar, Christopher S Mathews, Karin Denton, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2013
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assayMatejka Rebolj, Sarah Preisler, Ditte M Ejegod, et al.
Scandinavian Journal of Public Health|March 7, 2015
Mothers' and their daughters' use of preventive measures against cervical cancerBente Braad Sander, Miguel Vázquez-Prada, Matejka Rebolj, et al.
Endoscopy International Open|May 6, 2024
Adherence to follow-up and resource use after abnormal FIT-screening: Evaluation of the Danish colorectal cancer screening programSusanne Fogh Jørgensen, Pernille Thordal Larsen, Rune Erichsen, et al.
International Journal of Cancer|April 22, 2026
Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised TrialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.
Pageof 9